文献速递脑血管病认知障碍与痴呆

医源性脑淀粉样血管病的疾病进展

Disease Progression in Iatrogenic Cerebral Amyloid Angiopathy.
PubMed 文献 · Neurology · 2026-09-29

本研究纳入4个欧洲国家82例符合改良Queen Square标准的可能或很可能医源性脑淀粉样血管病(iCAA)患者,中位随访3.8年。结果显示症状性颅内出血(ICH)发生率高,达19.2/100患者年,初始表现为ICH者复发风险更高(HR 3.14),但死亡率较低(7.3%)。

要点

  • iCAA患者后续症状性ICH年风险约20%,初始表现为ICH者复发风险更高。
  • 脊髓手术暴露者ICH发生率低于脑手术或栓塞暴露者(HR 0.34)。
  • 尽管ICH频繁,随访期间死亡率较低(7.3%)。

核心结论

  • iCAA患者在 presumed 暴露后经长潜伏期,后续症状性ICH发生率高,年风险约20%,初始表现为ICH者复发风险最高。

研究设计与样本

  • 系统文献检索较大病例系列(n≥5)后,纳入4个欧洲国家82例符合改良Queen Square标准的可能或很可能iCAA患者,进行回顾性队列分析。

主要发现

  • 82例患者中50%初始表现为ICH,32.9%为cSAH/短暂局灶性神经发作;中位随访3.8年(IQR 1.8-5.9;总随访385患者年)期间发生74例症状性ICH,率为19.2/100患者年。
  • 初始表现为ICH者复发ICH风险增加(HR 3.14,95%CI 1.55-6.33,p=0.001),复发率24.6/100患者年(95%CI 18.2-32.6)。
  • 脊髓手术暴露者(n=24)ICH发生率低于脑手术或栓塞暴露者(HR 0.34,95%CI 0.13-0.87,p=0.02)。
  • 随访期间6例(7.3%)死亡;末次认知评估(中位1.9年)时42例(51.2%)记录有认知障碍。

关键数值与推荐

  • iCAA诊断采用改良Queen Square标准(可能或很可能)。
  • 症状性ICH年风险19.2/100患者年;初始ICH者复发率24.6/100患者年。
  • 脊髓手术暴露对比脑手术/栓塞的ICH HR 0.34(95%CI 0.13-0.87,p=0.02)。

临床怎么用

  • 对iCAA患者应警惕高频率的后续症状性ICH,尤其初始表现为ICH者需加强监测。
  • 暴露途径(脊髓手术 vs 脑手术/栓塞)可能影响ICH风险,临床评估时应考虑。

局限性

  • 样本量较小(82例),随访时间中位3.8年,可能不足以评估长期结局。
  • 仅纳入欧洲4国患者,结果外推需谨慎。
  • 回顾性设计可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Iatrogenic cerebral amyloid angiopathy (iCAA), likely caused by transmission of amyloid-beta by medical procedures, is a rare but distinct cerebral amyloid angiopathy (CAA) subtype, with rising numbers of patients identified globally. However, given its relatively recent recognition, data on long-term outcomes and prognosis are scarce. Therefore, we aimed to investigate the clinical disease progression in patients diagnosed with iCAA. METHODS: After a systematic literature search for larger case series of iCAA (n ≥ 5), we included patients from 4 European countries (Austria, Italy, The Netherlands, and the United Kingdom) meeting modified Queen Square criteria for possible or probable iCAA. Clinical outcomes of interest were symptomatic intracerebral hemorrhage (ICH), convexity subarachnoid hemorrhage (cSAH), cognitive status at last follow-up, and mortality. We used Cox regression to investigate clinical variables associated with those outcome events. RESULTS: We included 82 patients (59.8% male, median age at presentation 50 years, median latency from exposure 39 years); 50% of patients initially presented with ICH and 32.9% with cSAH/transient focal neurologic episodes. During a median follow-up time of 3.8 years (IQR 1.8-5.9; total follow-up 385 patient-years), 74 symptomatic ICH occurred, corresponding to a rate of 19.2 per 100 patient-years after first presentation. Patients who initially presented with ICH had an increased rate of recurrent ICH compared with other presentations (hazard ratio 3.14, 95% CI 1.55-6.33, p = 0.001) with a recurrence rate of 24.6 per 100 patient-years (95% CI 18.2-32.6). Patients with spinal surgery as an exposure (n = 24) had a lower rate of ICH compared with brain surgery or embolization (hazard ratio 0.34, 95% CI 0.13-0.87, p = 0.02). Six patients (7.3%) died during the follow-up period (initial presentation with ICH in 3, cSAH in 3). Cognitive impairment at last available cognitive evaluation (median 1.9 years from first presentation) was recorded in 42 patients (51.2%). DISCUSSION: Following a long latency from presumed exposure, patients diagnosed with iCAA have a high rate of subsequent symptomatic ICH (∼20% yearly risk), with recurrence risk being the highest among patients initially presenting with ICH and those exposed by brain rather than spinal surgery. The mortality rate was low despite the high frequency of ICH.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Fandler-Höfler S, Storti B, Kaushik K, et al. Disease Progression in Iatrogenic Cerebral Amyloid Angiopathy. Neurology. 2026. PMID: 42809801. doi:10.1212/WNL.0000000000218511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。